Ben Haynor
Stock Analyst at Lake Street
(1.01)
# 2,640
Out of 4,479 analysts
35
Total ratings
34.29%
Success rate
-22.01%
Average return
Main Sectors:
17 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
EKSO Ekso Bionics Holdings | Initiates: Buy | $2.5 | $1.03 | +142.72% | 1 | Jun 24, 2024 | |
ICCM IceCure Medical | Maintains: Buy | $1.9 → $2.9 | $0.74 | +291.26% | 3 | Mar 20, 2024 | |
PROF Profound Medical | Maintains: Buy | $13 → $11 | $8.58 | +25.87% | 3 | Mar 11, 2024 | |
EVGN Evogene | Initiates: Buy | $1.85 | $0.67 | +176.12% | 1 | Oct 2, 2023 | |
NNOX Nano-X Imaging | Initiates: Buy | $15 | $6.85 | +111.68% | 1 | Sep 8, 2023 | |
AWH Aspira Women's Health | Initiates: Buy | $5.6 | $1.03 | +443.69% | 1 | Aug 22, 2023 | |
NMTC NeuroOne Medical Technologies | Maintains: Buy | $3.25 → $2.2 | $0.87 | +153.11% | 1 | Aug 15, 2023 | |
DRIO DarioHealth | Maintains: Buy | $5.45 → $4.1 | $1.18 | +247.46% | 3 | Aug 11, 2023 | |
TTOO T2 Biosystems | Maintains: Neutral | $12 → $7 | $5.08 | +37.80% | 7 | Jul 13, 2023 | |
BEAT HeartBeam | Maintains: Buy | $10 → $5.55 | $2.95 | +88.14% | 2 | May 19, 2023 | |
NSPR InspireMD | Maintains: Buy | $5.15 → $4.75 | $2.43 | +95.47% | 3 | May 17, 2023 | |
SRTS Sensus Healthcare | Maintains: Buy | $15 → $7 | $4.93 | +41.99% | 3 | May 4, 2023 | |
CLGN CollPlant Biotechnologies | Initiates: Buy | $23 | $4.96 | +358.67% | 1 | Feb 17, 2023 | |
MYO Myomo | Maintains: Buy | $10 → $6.7 | $2.81 | +138.43% | 2 | Jul 8, 2022 | |
RSLS ReShape Lifesciences | Maintains: Buy | $275 → $233 | $0.19 | +120,553.87% | 1 | May 26, 2022 | |
OPGN OpGen | Maintains: Buy | $1,130 → $1,400 | $2.62 | +53,335.11% | 1 | Mar 2, 2021 | |
IBIO iBio, Inc. | Initiates: Buy | $1,375 | $1.95 | +70,412.82% | 1 | Jun 26, 2020 |
Ekso Bionics Holdings
Jun 24, 2024
Initiates: Buy
Price Target: $2.5
Current: $1.03
Upside: +142.72%
IceCure Medical
Mar 20, 2024
Maintains: Buy
Price Target: $1.9 → $2.9
Current: $0.74
Upside: +291.26%
Profound Medical
Mar 11, 2024
Maintains: Buy
Price Target: $13 → $11
Current: $8.58
Upside: +25.87%
Evogene
Oct 2, 2023
Initiates: Buy
Price Target: $1.85
Current: $0.67
Upside: +176.12%
Nano-X Imaging
Sep 8, 2023
Initiates: Buy
Price Target: $15
Current: $6.85
Upside: +111.68%
Aspira Women's Health
Aug 22, 2023
Initiates: Buy
Price Target: $5.6
Current: $1.03
Upside: +443.69%
NeuroOne Medical Technologies
Aug 15, 2023
Maintains: Buy
Price Target: $3.25 → $2.2
Current: $0.87
Upside: +153.11%
DarioHealth
Aug 11, 2023
Maintains: Buy
Price Target: $5.45 → $4.1
Current: $1.18
Upside: +247.46%
T2 Biosystems
Jul 13, 2023
Maintains: Neutral
Price Target: $12 → $7
Current: $5.08
Upside: +37.80%
HeartBeam
May 19, 2023
Maintains: Buy
Price Target: $10 → $5.55
Current: $2.95
Upside: +88.14%
InspireMD
May 17, 2023
Maintains: Buy
Price Target: $5.15 → $4.75
Current: $2.43
Upside: +95.47%
Sensus Healthcare
May 4, 2023
Maintains: Buy
Price Target: $15 → $7
Current: $4.93
Upside: +41.99%
CollPlant Biotechnologies
Feb 17, 2023
Initiates: Buy
Price Target: $23
Current: $4.96
Upside: +358.67%
Myomo
Jul 8, 2022
Maintains: Buy
Price Target: $10 → $6.7
Current: $2.81
Upside: +138.43%
ReShape Lifesciences
May 26, 2022
Maintains: Buy
Price Target: $275 → $233
Current: $0.19
Upside: +120,553.87%
OpGen
Mar 2, 2021
Maintains: Buy
Price Target: $1,130 → $1,400
Current: $2.62
Upside: +53,335.11%
iBio, Inc.
Jun 26, 2020
Initiates: Buy
Price Target: $1,375
Current: $1.95
Upside: +70,412.82%